Drugs / AGN201781
last change Jun 2008 re-read 3 minutes ago

AGN201781

Developed for
neuralgia
Investigated by
Allergan

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00533351 Mar → Jun 2008 neuralgia Allergan Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AGN201781 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00533351 ↗